Please contact the Biodesix Support Hotline at 1.866.432.5930 with any questions you may have regarding coverage and payment.



For patients with Medicare:

  • VeriStrat® is covered by Medicare for patients with non-small cell lung cancer who are EGFR wild-type or whose EGFR mutation status is unknown.
  • The genes tested in GeneStrat are covered by Medicare.

For patients with private insurance:

  •  Biodesix® will file the claim and any necessary appeal with the patient’s insurance company. VeriStrat and the genes tested in GeneStrat have positive medical policy with a large number of National and Regional Health Plans.

Biodesix Assist™ Financial Support Program:

  • If the patient has a financial responsibility, the patient’s insurance does not cover VeriStrat, or the patient does not have insurance, they may be eligible for the Biodesix Assist Financial Support Program, which may help to reduce or eliminate the cost of the test. Call a VeriStrat Patient Advocate to learn more at 1.866.432.5930.

Biodesix’s VeriStrat test has medical policy coverage for over 228 million lives*, including those at:

BCBS of Louisiana
BCBS of Michigan
Capital Health Plan
CareFirst BCBS
eviCore National Lab Management Program Guidelines
Florida Blue
Group Health Cooperative
Health Alliance Plan (HAP) of Michigan
Health Care Services Corporation (HCSC) including BCBS of Texas, Oklahoma, Illinois, Montana, and New Mexico
Health Net, Inc.
Highmark Inc., a BCBS affiliate
Horizon BCBS of New Jersey
Independence BlueCross
Priority Health Michigan
United Healthcare
Wellmark BCBS

*As of December, 2016